The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines helped control the spread of the virus, the emergence of new variants continues ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations that increased transmissibility or helped the virus evade our immune ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

Having this knowledge from our model would help with readiness for detecting ... SARS-CoV-2 variants with human host cells, Momeni said. The spike protein of the coronavirus, or SARS-CoV-2, binds to ...

Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before ... Subscribe for FREE Many of these key mutations are in the spike protein, ...

Researchers have discovered a virus that could enter human cells in a similar way to COVID-19. But they caution it's much more poorly adapted to humans.

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...